Announcements Trials
Browse Landscape

Status

Completed 14Recruiting 4Terminated 2No longer available 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Sarcoma 5Gastrointestinal 5CNS 1

Conditions

Glioblastoma 11Glioma 7Neuroblastoma 6Pheochromocytoma 3Paraganglioma 2Melanoma 2Diffuse Intrinsic Pontine Glioma 2Wilms Tumor 1Thyroid cancer, medullary 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Pinealoma 1Oligodendroglioma 1Neurofibromatosis 2 1Neuroectodermal Tumors, Primitive 1Neoplasms by Site 1Neoplasms 1Meningeal Neoplasms 1Meningeal Carcinomatosis 1Medulloblastoma 1Insulinoma 1Hepatoblastoma 1Gastrointestinal Stromal Tumors 1Dysbiosis 1Disease Progression 1Disease 1Carcinoid Tumor 1Breast Neoplasms 1

Interventions

avapritinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
No longer available × Gastrointestinal Stromal Tumors × CNS × Clear all
NCT04714086 2024-10-24

Expanded Access Program for Avapritinib

Blueprint Medicines Corporation

No longer available
CNSGastrointestinalSarcoma

Glioma, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡